BRYNJELSEN SEAN — SEC Form 4 filings
SEC reporting owner CIK 1669976. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-20.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-15 to 2026-08-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 3 filings — 430,000 shares, $13,506,101 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 119,852 shares @ $31.88 ($3,820,882) in Eton Pharmaceuticals, Inc., filed 2026-05-29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | President & CEO, Director | 9 | — | 11 legs · 430,000 sh · $13,506,101 | 12 |
Form 4 filings — BRYNJELSEN SEAN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-20 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Sale (S): 8,978 @ $62.65 · Sale (S): 47,307 @ $60.17 · Sale (S): 36,373 @ $61.11 · Sale (S): 7,342 @ $62.12 | EDGAR |
| 2026-08-04 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Grant/award (A): 128,985 (derivative) @ $0 | EDGAR |
| 2026-07-14 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Option exercise (M): 27,500 · Option exercise (M): 200,000 @ $1.37 · Option exercise (M): 27,500 (derivative) @ $0 · Option exercise (M): 200,000 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Sale (S): 119,852 @ $31.88 · Sale (S): 148 @ $32.67 | EDGAR |
| 2026-01-14 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Tax withholding (F): 5,015 @ $15.39 · Grant/award (A): 158,046 (derivative) @ $0 · Grant/award (A): 100,517 (derivative) @ $0 | EDGAR |
| 2025-12-12 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Tax withholding (F): 6,732 @ $16.83 | EDGAR |
| 2025-06-05 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Sale (S): 60,945 @ $17.38 · Sale (S): 8,655 @ $18.38 · Sale (S): 400 @ $19.02 · Sale (S): 70,000 @ $17 · Sale (S): 70,000 @ $16.81 | EDGAR |
| 2025-01-06 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Grant/award (A): 107,469 (derivative) @ $0 · Grant/award (A): 72,004 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Grant/award (A): 438,633 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1669976 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →